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Introduction
Parenteral drug addiction is an important problem in
health care programs and is associated with a wide range
of medical complications. Infective endocarditis (IE)
is one of the most serious complications, with an esti-
mated incidence of 1.5–3.3 cases per 1,000 injection-
drug users per year.1 Recurrent IE is also common in
intravenous drug users (IVDUs).1,2 The clinical char-
acteristics of IE in IVDUs are different from those in
non-IVDUs.3
Staphylococcus aureus is the most frequent pathogen
in IE.4 Its pathogenicity is related to various bacterial
surface components and extracellular proteins. Staph-
ylococcal γ-hemolysin (Hlg) and Panton-Valentine
leukocidin (PVL) belong to the family of synergohy-
menotropic toxins. These 2 component and hetero-
oligomeric pore-forming cytolytic toxins only exist in
staphylococcal strains.5 Hlg is produced by more than
99% of S. aureus clinical strains, but PVL was detected
in fewer than 5% of cases in France.6 PVL production
has been associated with skin and soft tissue infection
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and pneumonia, but has not been detected in strains
responsible for endocarditis.7–9
Methicillin-resistant S. aureus (MRSA) was first re-
ported in the early 1960s and identified as a nosocomial
pathogen. However, cases of MRSA have been docu-
mented among healthy, community-dwelling patients
without established risk factors for MRSA acquisition.
Community-associated (CA) and health care-associated
(HA) MRSA cases differ demographically and clini-
cally. CA-MRSA cases are characterized by limited re-
sistance to antibiotics, with cellulitis and abscesses as
the major clinical manifestations. They have a common
pulsed-field gel electrophoresis pattern but possess dif-
ferent exotoxin gene profiles (e.g. PVL) and harbor
the type IV staphylococcal cassette chromosome mec
(SCCmec). In contrast, HA-MRSA are mainly types I
to III SCCmec.8–12
This study investigated the clinical characteristics
of IE in IVDUs. The molecular patterns of MRSA,
including Hlg, PVL and SCCmec, that cause IE in
IVDUs were also evaluated.
Methods
Study subjects
The study was conducted at Kaohsiung Veterans
General Hospital, which is a 1,250-bed tertiary care
teaching hospital in Southern Taiwan. Consecutive hos-
pitalized IVDUs with a diagnosis of IE from November
1980 to July 2006 were included in this retrospective
study. The diagnosis of IE was based on the modified
Duke criteria.13
Clinical and laboratory data were recorded from
medical chart reviews starting from the times 
of admission. The site of IE involvement was identi-
fied by echocardiography. Septic pulmonary emboli
were diagnosed when the typical finding was
described in a radiological report. Stroke and non-
cerebral systemic emboli were diagnosed when clini-
cally documented.
Definitions of CA-MRSA and HA-MRSA
A CA-MRSA case was defined as a patient with an
MRSA infection identified within 48 hours of admis-
sion without any of the following established risk-
factors: (1) a history of hospitalization, surgery, dialysis,
or residence in a long-term care facility within 1 year
of the MRSA culture; (2) a permanent indwelling cath-
eter or percutaneous medical device present at the time
of culture; and (3) a known positive culture for MRSA
before the study period.10 An HA-MRSA case was de-
fined as a patient with an MRSA infection identified
more than 72 hours after admission with at least 1 of
the above risk factors.
Tests for hepatitis B and hepatitis C viruses
To determine the coinfection of hepatitis B and hepa-
titis C viruses, we conducted a microparticle enzyme
immunoassay with an Abbott AxSYM analyzer (Abbott
Laboratories, Abbott Park, IL, USA) to detect anti-
HCV and HBsAg.
Detection of accessory genes by polymerase 
chain reaction (PCR)
Using PCR, we determined that there are 2 specific
staphylococcal virulence genes (Hlg and PVL) as des-
cribed previously.7 Four main loci (A, B, D, and E) were
chosen for multiplex PCR, as described by Oliveira and
de Lencastre, to type the SCCmec in MRSA.14 The
mecA gene was used for internal positive control.
The overall genetic background of the isolates 
was evaluated by digesting whole-cell DNA with
SmaI macro-restriction enzyme and determining the
fragment-size patterns obtained on pulsed-field gel
electrophoresis using CHEF DR-II apparatus (Bio-
Rad Laboratories, Marnes-la-Coquette, France) as
described elsewhere.15 Resolved macro-restriction pat-
terns were compared as recommended by Tenover 
et al.15 Isolates differing by up to 3 fragments were
considered as subtypes of a given clonal type.
Statistical analysis
Similarities between strains were calculated using the
Pearson correlation coefficient. Frequencies (in
percentages) were calculated for numbers of cases.
Categorical data were analyzed with the Fisher exact
test. A p value < 0.05 was considered statistically 
significant.
Results
A total of 37 episodes of IE among 31 IVDUs hospi-
talized from 1980 to 2006 were retrospectively evalu-
ated. Of the 37 episodes of IE in the 31 patients, there
were 28 episodes (76%) in men and 9 episodes (24%)
in women (Table 1). Heroin was the illicit drug used
by all of the IVDUs. There were no episodes of IE
between 1980 and 1996. Five of 37 episodes occurred
from 1997 to 2001, and the other 32 episodes occurred
between 2001 and 2006.
Blood culture positive for S. aureus was identified in
35 of the 37 episodes (95%). Gram-negative bacteria
were identified in 3 episodes (8%): Serratia marcescens
in 1 episode, Enterobacter cloacae in 1, and Klebsiella
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pneumoniae in 1. Candida albicans and Group B
Streptococcus were also noted in 1 case each. Two epi-
sodes were culture-negative and 2 episodes were poly-
microbial (methicillin-sensitive Staphylococcus aureus
[MSSA] and K. pneumoniae in 1, and MRSA and
Group B Streptococcus in the other). Four patients had
2 episodes of IE caused by MSSA, and 1 patient had 
2 episodes of infection caused by MSSA that became
MRSA in the third episode 6 months later. Eight of
the 31 patients (26%) had a prior history of IE, and 1
(3%) had a history of congenital heart disease (tetral-
ogy of Fallot s/p surgical reconstruction).
Embolic phenomena or metastatic foci were noted
in 25 episodes (68%), including 19 pulmonary septic
emboli (51%), 6 conjunctival hemorrhage (16%), 4
Janeway’s lesions (11%), 2 cerebrovascular events (5%),
2 splenic infarct (5%), and 2 epidural abscesses (5%).
Echocardiography was performed in the 35 of the
37 episodes (95%). The right side of the heart alone
was involved in 21 episodes (60%).
Medical treatment only was given in 32 episodes of
IE (87%), while 5 (14%) patients underwent surgical
intervention. The type of surgery was valve replace-
ment in 3 patients, thoracoscopy for empyema in 1,
and total laminectomy for epidural abscess in 1. One
(20%) of the 5 cases who underwent surgery died.
Seven (22%) of the 26 medically treated cases also
died. The overall mortality rate was 22%.
The clinical manifestations of IE between patients
with MRSA and MSSA infections were not signifi-
cantly different. There was no significant difference in
clinical presentation between patients with and with-
out HIV.
We obtained 4 strains of MRSA (1 isolate for each
patient, 2 isolates in 2004 and 2 isolates in 2006),
which all belonged to CA-MRSA. The antibiogram 
of the 4 strains showed that all of them were sensitive
to ciprofloxacin, levofloxacin, rifampicin, trimetho-
prim/sulfamethoxazole and vancomycin. The molec-
ular patterns of MRSA are summarized in Table 2.
Multiplex PCR for SCCmec typing showed that 3
strains were SCCmec III, and 1 was untypeable.
Pulsed-field gel electrophoresis patterns of MSSA
strains were considered unrelated, but 80% similarities
were found in the MRSA strains (Figure 1). Hlg
genes and PVL genes were found in 3 and 2 strains,
respectively. The PCR product for PVL was verified
by subjecting the sample to gene sequencing using
ABI 310 gene analyzer (Applied Biosystems, Foster
City, CA, USA) based on the Sanger dideoxy nu-
cleotide triphosphate (ddNTP) terminator method.
One of 2 cases with PVL-producing MRSA infection
had cellulitis on the left hand where heroin was
injected. Another case did not have skin lesions, but
had multiple complications, including septic shock,
multiple organ failure, epidural abscess, and throm-
bocytopenia, and died 3 days after disease onset.
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Table 1. Clinical manifestations of infective endocarditis in 31
intravenous drug users in Southern Taiwan
Age (yr), mean ± SD 31.51 ± 9.25
Male, n (%) 28 (75.7)



















Laboratory data, mean ± SD 
(range)
Leukocyte count, 103/mm3 12.7 ± 5.6 (4–9)
Hemoglobin, g/dL 11.1 ± 2.6 (12–17.5)
Platelet count, 103/mm3 178.8 ± 118.9 (150–450)
AST, U/L 66.5 ± 97.5 (5–35)
ALT, U/L 54.9 ± 70.9 (0–40)
Total bilirubin, mg/dL 1.2 ± 0.8 (0.2–1.6)
Creatinine, mg/dL 2.3 ± 0.5 (0.5–1.5)
CRP, mg/dL 19.1 ± 13.4 (< 1.0)
SD = standard deviation; IE = infective endocarditis; HCV = hepatitis C virus;
HBV = hepatitis B virus; HIV = human immunodeficiency virus; AST = aspar-
tate aminotransferase; ALT = alanine aminotransferase; CRP = C-reactive 
protein.
Table 2. Molecular patterns of methicillin-resistant
Staphylococcus aureus strains in 4 patients with intravenous
drug-related infective endocarditis
Strain 1 2 3 4
SCCmec type Nontypeable III III III
Hlg gene + + – +
PVL gene – + – +
SCCmec = staphylococcal cassette chromosome mec; Hlg = staphylococcal 
g-hemolysin; PVL = Panton-Valentine leukocidin.
Discussion
In this investigation, a high incidence (11%) of IE
caused by MRSA in IVDUs was noted. Mathew and
colleagues also reported that MRSA accounted for
15% of the microorganisms identified in IE among
IVDUs.16 Moreover, the PVL gene was detected in 
2 of the 4 MRSA strains. To our knowledge, this is
the first report on the involvement of the PVL gene in
IE. Three MRSA strains were SCCmec type III, i.e. the
type that was associated with hospital-acquired infec-
tion in previous reports17,18 was community-associated
in our study.
MRSA is usually considered a nosocomial patho-
gen although the incidence of CA-MRSA is increas-
ing. In Taiwan, a substantial proportion of healthy
children are colonized with MRSA. This accounts for
25–75% of childhood community-acquired S. aureus
infections.11,19 SCCmec types IV and VT have been
detected in Taiwanese children.20 The colonization
rate of CA-MRSA in Southern Taiwan is 3.5%, and
SCCmec type IV is the most common (87.5%).18
In a worldwide study of CA-MRSA, all strains
shared a type IV SCCmec.8 Three of our 4 MRSA iso-
lates were SCCmec type III. However, there were no
established risk factors for MRSA acquisition in these
3 patients. Huang et al found that 12% of their CA-
MRSA isolates were SCCmec type III. 21 Another study
also demonstrated that SCCmec type III was found in
10% of patients with CA-MRSA.19 These results sug-
gest that SCCmec type III, which is usually hospital-
acquired, can cause CA-MRSA endocarditis.
PVL-producing S. aureus appear to be associated
with furunculosis, cutaneous abscesses, severe necrotic
skin infections, and severe hemorrhagic pneumonia.
But the PVL gene is rarely found in other infections,
such as osteomyelitis, septicemia, or endocarditis.7,9,12
The PVL gene is frequently detected in CA-MRSA,8,9,12
and there were 2 PVL-producing MRSA isolates from
our patients. One patient had cellulitis over the site of
heroin injection and the other presented with fulmi-
nant sepsis. Since the prevalence of the PVL gene in
Taiwan is unknown, the high frequency (50%) of the
PVL gene detected in our MRSA isolates reflects the
high prevalence of PVL-producing S. aureus in Taiwan.
Nonetheless, the clinical significance of the PVL gene
in IE remains difficult to define because of our small
study population.
The clinical characteristics of our patients were sim-
ilar to those of previous reports.2,3,22 The patients were
young and predominantly male. The tricuspid valve
was the most affected site, and S. aureus accounted
for 95% of infections. In our studies, abnormal liver
and renal functions were noted. The high prevalence
of coinfection with HCV could explain the elevated
levels of aminotransferases. Multiple factors, includ-
ing sepsis, endocarditis-related glomerulonephritis, and
heroin-related renal toxicity, may have contributed to
the impaired renal function.23
There were several limitations in this study. First,
the case number was small. The data on the molecular
pattern of MRSA could not reveal the actual condi-
tion, and the clinical significance could not be conclu-
sively drawn out. Second, this was a retrospective study.
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Figure 1. Pulsed-field gel electrophoresis patterns of chromosomal DNA restriction fragments of methicillin-susceptible Staphylococcus
aureus and methicillin-resistant S. aureus strains. Group A is the methicillin-resistant S. aureus strain and indistinguishable at the 80%
similarity level. Groups B to J are the methicillin-susceptible S. aureus strains. No major clone was found.
Additional data, especially regarding rheumatoid fac-
tor and the serological status of HIV, HCV and HBV
infection, could have given a better overall perspective.
There was also the possibility of incomplete history of
health care facility exposure, so the discrimination be-
tween CA-MRSA and HA-MRSA could be incorrect.
In conclusion, IE among IVDUs has a unique clin-
ical picture. Coinfection with HIV and viral hepatitis
remains a public health issue. More caution is necessary
to slow the emergence of MRSA, and further study
about the specific typing of SCCmec and accessory
genes in this group is needed.
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